Yücel Erbilgin

428 total citations
25 papers, 263 citations indexed

About

Yücel Erbilgin is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Yücel Erbilgin has authored 25 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 13 papers in Molecular Biology and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Yücel Erbilgin's work include Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (9 papers) and Cancer-related gene regulation (9 papers). Yücel Erbilgin is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (9 papers) and Cancer-related gene regulation (9 papers). Yücel Erbilgin collaborates with scholars based in Türkiye, Hungary and United Kingdom. Yücel Erbilgin's co-authors include Uğur Özbek, Müge Sayitoğlu, Özden Hatırnaz Ng, Tiraje Çelkan, Çetin Timur, Gönül Aydoğan, Karl‐Johan Leuchowius, Karin Grannas, Agata Zieba and Carl-Magnus Clausson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular & Cellular Proteomics and British Journal of Haematology.

In The Last Decade

Yücel Erbilgin

22 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yücel Erbilgin Türkiye 8 170 82 65 40 37 25 263
L. T. F. Van De Locht Netherlands 9 181 1.1× 108 1.3× 43 0.7× 66 1.6× 41 1.1× 9 283
Esther Tijchon Netherlands 9 218 1.3× 87 1.1× 91 1.4× 64 1.6× 21 0.6× 15 339
Shaowei Qiu China 10 180 1.1× 184 2.2× 44 0.7× 71 1.8× 53 1.4× 67 344
Sabine Juge Switzerland 7 253 1.5× 155 1.9× 24 0.4× 49 1.2× 20 0.5× 10 314
Valentina Agnusdei Italy 10 205 1.2× 69 0.8× 79 1.2× 65 1.6× 21 0.6× 11 316
Elena Vendramini Italy 7 150 0.9× 69 0.8× 51 0.8× 46 1.1× 54 1.5× 10 232
Lorenz Bastian Germany 7 86 0.5× 73 0.9× 59 0.9× 55 1.4× 29 0.8× 24 209
Claude Denis France 7 178 1.0× 188 2.3× 31 0.5× 40 1.0× 83 2.2× 9 301
Klaudia Hettinger Austria 5 139 0.8× 55 0.7× 69 1.1× 54 1.4× 17 0.5× 7 246
Marco De Dominici United States 10 188 1.1× 107 1.3× 27 0.4× 84 2.1× 43 1.2× 17 293

Countries citing papers authored by Yücel Erbilgin

Since Specialization
Citations

This map shows the geographic impact of Yücel Erbilgin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yücel Erbilgin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yücel Erbilgin more than expected).

Fields of papers citing papers by Yücel Erbilgin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yücel Erbilgin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yücel Erbilgin. The network helps show where Yücel Erbilgin may publish in the future.

Co-authorship network of co-authors of Yücel Erbilgin

This figure shows the co-authorship network connecting the top 25 collaborators of Yücel Erbilgin. A scholar is included among the top collaborators of Yücel Erbilgin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yücel Erbilgin. Yücel Erbilgin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erbilgin, Yücel, Zeynep Karakaş, Ayşegül Ünüvar, et al.. (2025). Status of IKZF1 Deletions in Diagnose and Relapsed Pediatric B-ALL Patients. Biochemical Genetics. 64(1). 152–167.
2.
Erbilgin, Yücel, et al.. (2024). A novel germline Pregnane X Receptor (PXR) variant predisposing to Hodgkin lymphoma in two siblings. European Journal of Medical Genetics. 72. 104975–104975.
3.
Erbilgin, Yücel, Özden Hatırnaz Ng, Serap Karaman, et al.. (2023). Impact of TP53 gene variants on prognosis and survival of childhood acute lymphoblastic leukemia. Scandinavian Journal of Clinical and Laboratory Investigation. 83(3). 187–193. 2 indexed citations
4.
Desterke, Christophe, Paul Marcoux, Yücel Erbilgin, et al.. (2023). Modeling Blast Crisis Using Mutagenized Chronic Myeloid Leukemia-Derived Induced Pluripotent Stem Cells (iPSCs). Cells. 12(4). 598–598. 5 indexed citations
5.
Sayitoğlu, Müge, et al.. (2023). NOVEL RUNX1 VARIATION IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA. Mediterranean Journal of Hematology and Infectious Diseases. 15(1). e2023036–e2023036.
6.
Ng, Özden Hatırnaz, Yücel Erbilgin, Özkan Özdemir, et al.. (2023). Obstacles and expectations of rare disease patients and their families in Türkiye: ISTisNA project survey results. Frontiers in Public Health. 10. 1049349–1049349. 4 indexed citations
7.
Erbilgin, Yücel, Özden Hatırnaz Ng, Serap Karaman, et al.. (2022). Zinc finger protein 384 ( ZNF384 ) impact on childhood mixed phenotype acute leukemia and B-cell precursor acute lymphoblastic leukemia. Leukemia & lymphoma. 63(12). 2931–2939. 4 indexed citations
8.
Erbilgin, Yücel, Özden Hatırnaz Ng, İsmail Can, et al.. (2021). Prognostic evidence of LEF1 isoforms in childhood acute lymphoblastic leukemia. International Journal of Laboratory Hematology. 43(5). 1093–1103. 6 indexed citations
9.
Kebudi, Rejin, Ayşenur Kaya, Yücel Erbilgin, et al.. (2020). Lymphoma Predisposing Gene in an Extended Family: CD70 Signaling Defect. Journal of Clinical Immunology. 40(6). 883–892. 3 indexed citations
10.
Erbilgin, Yücel, Özden Hatırnaz Ng, Zeynep Karakaş, et al.. (2019). PTEN and AKT1 Variations in Childhood T-cell Acute Lymphoblastic Leukemia. Turkish Journal of Hematology. 37(2). 98–103. 2 indexed citations
11.
Erbilgin, Yücel, Özden Hatırnaz Ng, Serap Karaman, et al.. (2019). Prognostic gene alterations and clonal changes in childhood B-ALL. Leukemia Research. 83. 106159–106159. 2 indexed citations
12.
Erbilgin, Yücel, Ahmet Emre Eşkazan, Özden Hatırnaz Ng, et al.. (2018). Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors. Leukemia & lymphoma. 60(1). 200–207. 11 indexed citations
13.
Ng, Özden Hatırnaz, et al.. (2017). Dysregulation of the DKK1 gene in pediatric B-cell acute lymphoblastic leukemia. TURKISH JOURNAL OF MEDICAL SCIENCES. 47(1). 357–363. 5 indexed citations
15.
Uz, Burak, Müge Sayitoğlu, Yücel Erbilgin, et al.. (2014). Local Renin-Angiotensin System in Normal Hematopoietic and Multiple Myeloma-Related Progenitor Cells. Turkish Journal of Hematology. 31(2). 136–142. 5 indexed citations
16.
Ng, Özden Hatırnaz, Yücel Erbilgin, Tiraje Çelkan, et al.. (2014). Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia. Blood Cancer Journal. 4(3). e192–e192. 58 indexed citations
17.
Leuchowius, Karl‐Johan, Carl-Magnus Clausson, Karin Grannas, et al.. (2013). Parallel Visualization of Multiple Protein Complexes in Individual Cells in Tumor Tissue. Molecular & Cellular Proteomics. 12(6). 1563–1571. 44 indexed citations
18.
Sayitoğlu, Müge, Yücel Erbilgin, Özden Hatırnaz Ng, et al.. (2012). Upregulation of T-Cell-Specific Transcription Factor Expression in Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL). SHILAP Revista de lepidopterología. 29(4). 325–333. 5 indexed citations
19.
Erbilgin, Yücel, et al.. (2011). ABL gene kinase domain mutation scanning by denaturing high performance liquid chromatography sequencing method. SHILAP Revista de lepidopterología. 28(2). 97–102. 5 indexed citations
20.
Erbilgin, Yücel, Müge Sayitoğlu, Özden Hatırnaz Ng, et al.. (2010). Prognostic significance of NOTCH1 and FBXW7 mutations in pediatric T-ALL.. PubMed. 28(6). 353–60. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026